GI
CORT icon

GAMMA Investing’s Corcept Therapeutics CORT Stock Holding History

GAMMA Investing’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$646K Buy
5,609
+969
+21% +$104K 0.02% 583
2026
Q2 		$403K Buy
4,640
+1,627
+54% +$98.2K 0.02% 772
2026
Q1 		$121K Sell
3,013
-1,863
-38% -$69.7K 0.01% 1523
2025
Q4 		$170K Buy
4,876
+239
+5% +$18.8K 0.01% 1158
2025
Q3 		$385K Buy
4,637
+857
+23% +$62K 0.02% 600
2025
Q2 		$277K Buy
3,780
+373
+11% +$27K 0.02% 711
2025
Q1 		$389K Buy
3,407
+411
+14% +$25K 0.03% 505
2024
Q4 		$151K Buy
2,996
+506
+20% +$26.5K 0.01% 848
2024
Q3 		$115K Buy
2,490
+1,147
+85% +$40.8K 0.01% 906
2024
Q2 		$43.6K Buy
1,343
+125
+10% +$3.42K 0.01% 1299
2024
Q1 		$30.7K Buy
1,218
+579
+91% +$13.7K 0.01% 1354
2023
Q4 		$13.5K Buy
+639
New +$17.5K ﹤0.01% 1739

Other funds holding CORT

VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

GAMMA Investing's CORT Position: Q3 2026 in Review

GAMMA Investing increased its Corcept Therapeutics (CORT) stake by 21% in Q3 2026, buying an estimated $104K and bringing the position to 5,609 shares worth $646K. The position accounts for 0.02% of the portfolio, ranked #583.

GAMMA Investing first reported a position in CORT in Q4 2023 and has held it in 12 quarters since. 12 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • GAMMA Investing held 5,609 shares of Corcept Therapeutics worth $646K as of Q3 2026.
  • GAMMA Investing bought 969 Corcept Therapeutics shares in Q3 2026, an estimated $104K.
  • Corcept Therapeutics made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #583 holding.
  • GAMMA Investing first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • 12 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.